| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunitybio, Inc. (IBRX) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 27 sells. IBRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 29.82M | $249.75M | - | |
| CEO | 548.2K | $4.59M | - | |
| CFO | 322.8K | $2.70M | - | |
| Dir | 162.8K | $1.36M | - | |
| Dir | 162.8K | $1.36M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2018 | Gorlin Steve | Director | Sell | 151,159 | $1.74 | $263,109.94 | -23.2% | |
| Nov 23, 2018 | Gorlin Steve | Director | Sell | 32,212 | $2.02 | $64,933.90 | -5.2% | |
| Nov 14, 2018 | Gorlin Steve | Director | Sell | 196,280 | $2.29 | $450,068.33 | -42.5% | |
| Aug 27, 2018 | Gorlin Steve | Director | Sell | 50,000 | $3.07 | $153,512.67 | -7.3% | |
| Jun 7, 2018 | Gorlin Steve | Director | Sell | 79,456 | $3.73 | $296,225.07 | -7.1% | |
| May 30, 2018 | Gorlin Steve | Director | Sell | 2,724 | $3.88 | $10,563.94 | -0.7% | |
| May 29, 2018 | Gorlin Steve | Director | Sell | 6,003 | $3.94 | $23,668.38 | -0.2% | |
| May 22, 2018 | Gorlin Steve | Director | Sell | 14,103 | $3.85 | $54,232.56 | -1.7% | |
| May 18, 2018 | Gorlin Steve | Director | Sell | 15,971 | $3.97 | $63,412.86 | -3.6% | |
| May 17, 2018 | Gorlin Steve | Director | Sell | 81,743 | $4.05 | $331,453.34 | -5.5% |